Effects of long-term enalapril treatment on persistent microalbuminuria in normotensive type 2 diabetic patients: Results of a 4-year, prospective, randomized study

Diabetic Medicine

Volumn 13, Issue 2, 1996, Pages 120-124

  Sano, T ^a   Hotta, N ^b   Kawamura, T ^a   Matsumae, H ^a   Chaya, S ^a   Sasaki, H ^b   Nakayama, M ^a   Hara, T ^b   Matsuo, S ^b   Sakamoto, N ^a  

^a CHUBU ROSAI HOSPITAL   (Japan)

^b NAGOYA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

ACE inhibitor; Enalapril; Microalbuminuria; Non insulin dependent diabetes; Normotension

Indexed keywords

ENALAPRIL;

ADULT; AGED; ARTICLE; CLINICAL PROTOCOL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; HUMAN; MAJOR CLINICAL STUDY; MICROALBUMINURIA; NON INSULIN DEPENDENT DIABETES MELLITUS; RANDOMIZED CONTROLLED TRIAL;

AGED; ALBUMINURIA; ANALYSIS OF VARIANCE; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; BLOOD PRESSURE; DIABETES MELLITUS, TYPE 2; DIABETIC NEPHROPATHIES; DRUG ADMINISTRATION SCHEDULE; ENALAPRIL; FOLLOW-UP STUDIES; HUMANS; MIDDLE AGED; PROSPECTIVE STUDIES;

EID: 9044252719     PISSN: 07423071     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-9136(199602)13:2<120::AID-DIA6>3.0.CO;2-F     Document Type: Article

References (27)

1. Rettig B, Teutsch SM. The incidence of end stage renal disease in type I and type II diabetes mellitus. Diabetic Nephropathy 1984; 3: 26-27.
2. Klein R, Klien BE, Moss S, DeMets DL. Proteinuria in diabetes. Arch Intern Med 1988; 148: 181-186.
3. Nelson RG, Newman JM, Knowler WC, Sievers ML, Kunzelman CL, Petitt DJ, et al. Incidence of end-stage renal disease in type II (non-insulin-dependent) diabetes mellitus in Pima Indians. Diabetologia 1988; 31: 730-736.
4. Mogensen CE, Hansen KW. Preventing and postponing renal disease in insulin-dependent diabetes by glycemic and nonglycemic intervention. Contrib Nephron 1990; 78: 73-100.
5. Christlieb AR, Warram JH, Krolewski AS, Busick EJ, Ganda OP, Asmal AC, et al. Hypertension: The major risk factor in juvenile-onset insulin-dependent diabetics. Diabetes 1981; 30: 90-96.
6. Mogensen CE. Long-term antihypertensive treatment inhibiting progression of diabetic nephropathy. Br Med J 1982; 285: 685-688.
7. Parving HH, Andersen AR, Smidt UM, Christiansen JS, Oxenboll B, Svendsen PA. Diabetic nephropathy and arterial hypertension. The effect of antihypertensive treatment. Diabetes 1983; 32: 83-87.
8. Parving HH, Hommel E, Damkjaer M, Giese J. Effect of captopril on blood pressure and kidney function in normotensive insulin dependent diabetics with nephropathy. Br Med J 1989; 299: 533-536.
9. Hasslacher CH, Wolfrum M, Stech G, Wahl P, Ritz E. Diabetische Nephropathie bei Type-II Diabetes. Dtsch Med Wochenschr 1987; 112: 1445-1449.
10. Mathiesen ER, Ronn B, Jensen T, Storm B, Deckert T. Relationship between blood pressure and urinary albumin excretion in development of microalbuminuria. Diabetes 1990; 39: 245-249.
11. Parving HH. Impact of blood pressure and antihypertensive treatment on incipient and overt nephropathy, retinopathy, and endothelial permeability in diabetes mellitus. Diabetes Care 1991; 14: 260-269.
12. Taguma Y, Kitamoto Y, Futaki G, Ueda H, Monma H, Ishizaki M, et al. Effect of captopril on heavy proteinuria in azotemic diabetics. N Engl J Med 1985; 313: 1617-1620.
13. Björk S, Nyberg G, Mulec H, Granerus G, Herlitz H, Aurell M. Beneficial effects of angiotensin converting enzyme inhibition on renal function in patients with diabetic nephropathy. Br Med J 1986; 293: 471-474.
14. Insua A, Ribstein J, Mimran A. Comparative effect of captopril and nifedipine in normotensive patients with incipient diabetic nephropathy. Postgrad Med J 1988; 64 (suppl 3): 59-64.
15. Marre M, Chatellier G, Leblanc H, Guyene TT, Menard J, Passa P. Prevention of diabetic nephropathy with enalapril in normotensive diabetics with microalbuminuria. Br Med J 1988; 297: 1092-1095.
16. Beuer JH, Reams GP, Hewett J, Klachko D, Lau A, Messina C, et al. A randomized, double-blind, placebo-controlled trial to evaluate the effect of enalapril in patients with clinical diabetic nephropathy. Am J Kidney Disease 1992; 20:443-457.
17. Stornello M, Valvo EV, Scapellato L. Persistent albuminuria in normotensive non-insulin-dependent (type II) diabetic patients: Comparative effects of angiotensin-converting enzyme inhibitors and β-adrenoceptor blockers. Clin Sci 1992; 82: 19-23.
18. Ravid M, Savin H, Jutrin I, Bental T, Katz B, Lishner M. Long-term stabilizing effect of angiotensin-converting enzyme inhibition on plasma creatinine and on proteinuria in normotensive type 2 diabetic patients. Ann Intern Med 1993; 118: 577-581.
19. Romero R, Salinas I, Lucas A, Abad E, Reverter JL, Johnston S, et al. Renal function changes in microalbuminuric normotensive type 2 diabetic patients treated with angiotensin-converting enzyme inhibitors. Diabetes Care 1993; 16: 597-600.
20. Sano T, Kawamura T, Matsumae H, Sasaki H, Nakayama M, Hara T, et al. Effects of long-term enalapril treatment on persistent microalbuminuria in well-controlled hypertensive and normotensive NIDDM patients. Diabetes Care 1994; 17: 420-424.
21. Baba T, Tomiyama T, Murabayashi S, Takebe K. Renal effects of nicardipine, a calcium antagonist, in hypertensive type 2 (non-insulin-dependent) diabetic patients with and without nephropathy. Diabetologia 1990; 38: 425-429.
22. Holdass H, Hartmann A, Lien MG, Nilsen L, Jervell J, Fauchald P, et al. Contrasting effects of lisinopril and nifedipine on albuminuria and tubular transport functions in insulin dependent diabetics with nephropathy. J Int Med 1991; 229: 163-170.
23. Parving HH, Andersen AR, Smidt UM, Hommel E, Mathiesen ER, Svendsen PA. Effect of antihypertensive treatment on kidney function in diabetic nephropathy. Br Med J 1987; 294: 1443-1447.
24. Elving LD, Wetzels JFM, van Lier HJJ, de Nobel E, Berden JHM. Captopril and atenolol are equally effective in retarding progression of diabetic nephropathy. Results of a 2-year prospective, randomized study. Diabetologia 1994; 37: 604-609.
25. Anderson S, Rennke HG, Brenner BM. Therapeutic advantage of converting enzyme inhibitors in arresting progressive renal disease associated with systemic hypertension in the rat. J Clin Invest 1986; 77: 1993-2000.
26. Hosteller TH, Rennke HG, Brenner BM. The case for intrarenal hypertension in the initiation and progression of diabetic and other glomerulopathies. Am J Med 1982; 72: 375-380.
27. Melchior WR, Bindlish V, Jaber LA. Angiotensin-converting enzyme inhibitors in diabetic nephropathy. Ann Pharmacother 1993; 27: 344-350.